---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-064879"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T07:55:06.579451+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# EyePoint posts updated investor presentation; no specific financial updates in excerpt

## Summary
- Filed investor presentation dated May 2024 as Exhibit 99.1 on May 28, 2024.
- Presentation posted on company website at www.eyepointpharma.com.
- No new financial guidance, clinical data, or material events disclosed in filing summary.
- Ticker EYPT; common stock listed on Nasdaq.
- No changes to previously disclosed business outlook or pipeline.

## SEC filing metadata
- accession: 0000950170-24-064879
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/0000950170-24-064879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/eypt-20240528.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-064879
- JSON: https://secwatch.observer/filing/0000950170-24-064879.json
- Plain text: https://secwatch.observer/filing/0000950170-24-064879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.